vaccine it is studying with pharmaceutical giant Merck fared well in a small study of patients who had the cancer surgically removed.
Phase 3 is generally the largest and most expensive stage of clinical research before regulators review a potential drug for approval. In a mid-stage clinical trial involving 157 patients, researchers compared the vaccine-Keytruda combination with Keytruda alone. The treatments continued for about a year in both groups unless the disease came back or side effects became too severe.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: